The technical advances in magnetic resonance imaging (MRI) in the last decade have made it the technique of choice in the overall management of patients with suspected or diagnosed prostate cancer.
MRI allows combining morphological and functional information at the same time through the application of sequences such as spectroscopy, diffusion and dynamic sequences with intravenous contrast in the same study.
MRI allows not only to focus the study on the gland but also to assess the regional extension to the whole pelvis or the whole body depending on the clinical indication, in less than 1 hour of exploration.
The main clinical indications for prostate MRI are: a) local, regional or distant statification; b) detection or guidance for diagnostic biopsy in the event of clinical suspicion or negative results in previous biopsies; and c) therapeutic monitoring.